Literature DB >> 1796496

Substrate-binding sites in acetylcholinesterase.

F Hucho1, J Järv, C Weise.   

Abstract

Acetylcholinesterase is among the most efficient enzymes known. In order to provide an explanation for its catalytic and regulatory mechanisms, including the high turnover rate, the specific amino acid residues involved in substrate binding and hydrolysis need to be identified. In this article, Ferdinand Hucho, Jaak Järv and Christoph Weise describe the topography of the enzyme as deduced from protein chemistry studies. One result of this approach is the finding that the binding pocket for the substrate's cationic cholinium group appears to be hydrophobic rather than anionic.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796496     DOI: 10.1016/0165-6147(91)90621-x

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  5 in total

Review 1.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis.

Authors:  B Velan; C Kronman; A Ordentlich; Y Flashner; M Leitner; S Cohen; A Shafferman
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

3.  Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism.

Authors:  P G Layer; T Weikert; R Alber
Journal:  Cell Tissue Res       Date:  1993-08       Impact factor: 5.249

4.  Multiple binding sites involved in the effect of choline esters on decarbamoylation of monomethylcarbamoyl- or dimethylcarbamoly-acetylcholinesterase.

Authors:  D E Sok; Y B Kim; S J Choi; C H Jung; S H Cha
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

5.  Mouse acetylcholinesterase enhances neurite outgrowth of rat R28 cells through interaction with laminin-1.

Authors:  Laura E Sperling; Janine Klaczinski; Corina Schütz; Lydia Rudolph; Paul G Layer
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.